NNAL Clearance in Hair and Urine

The recruitment status of this study is unknown because the information has not been verified recently.

Verified March 2009 by University of Nebraska.
Recruitment status was Not yet recruiting

Sponsor:

Collaborator:

Centers for Disease Control and Prevention

Information provided by:

University of Nebraska

ClinicalTrials.gov Identifier:

NCT00863824

First received: March 17, 2009

Last updated: NA

Last verified: March 2009

History: No changes posted

Purpose

The purpose of the study is to investigate how long it takes for NNAL and cotinine, both specific markers of second hand tobacco smoke exposure to clear the human body.

Condition
Lung Cancer

Study Type:	Observational
Study Design:	Observational Model: Case-Only Time Perspective: Prospective
Official Title:	Elimination of NNAL and Cotinine From Hair and Urine

Resource links provided by NLM:

MedlinePlus related topics: Cancer Lung Cancer Smoking Urine and Urination

U.S. FDA Resources

Further study details as provided by University of Nebraska:

Estimated Enrollment:	40
Study Start Date:	July 2009
Estimated Study Completion Date:	June 2010
Estimated Primary Completion Date:	May 2010 (Final data collection date for primary outcome measure)

Eligibility

Ages Eligible for Study:	19 Years to 75 Years
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	Yes
Sampling Method:	Non-Probability Sample

Study Population

Healthy Caucasians and African Americans who are ready to quit smoking.

Criteria

Inclusion Criteria:

Healthy caucasians and african americans 19 years of agae or above, how are ready to quit smoking

Exclusion Criteria:

Anyone who is not a caucasian or an african-american, below 19 years of age, and is currently taken prescription medication.

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00863824

Contacts

Contact: Chandran Achuatn, Ph.D.

402.559.8599

cachutan@unmc.edu

Locations

United States, Nebraska
University of Nebraska Medical Center	Not yet recruiting
Omaha, Nebraska, United States, 68198

Sponsors and Collaborators

University of Nebraska

Centers for Disease Control and Prevention

More Information

No publications provided

Responsible Party:	Gail Paulsen, UNMC
ClinicalTrials.gov Identifier:	NCT00863824 History of Changes
Other Study ID Numbers:	121-09-EP
Study First Received:	March 17, 2009
Last Updated:	March 17, 2009
Health Authority:	United States: Institutional Review Board

Keywords provided by University of Nebraska:

NNAL
Cotinine
Second hand smoke
NNAL is a known lung carcinogen. So, we are studying an agent that can potentially cause lung cancer.

Additional relevant MeSH terms:

Lung Neoplasms
Respiratory Tract Neoplasms
Thoracic Neoplasms
Neoplasms by Site

Neoplasms
Lung Diseases
Respiratory Tract Diseases

ClinicalTrials.gov processed this record on May 23, 2013

To Top